semaglutide oral cardiovascular indication 2025 news semaglutide oral cardiovascular indication 2025 news At ADA 2025, the Oral semaglutide found to lower

Those taking SGLT2 inhibitors alongside GLP-1/GIP medications face additional risks, including increased urination and potential for euglycemic diabetic ketoacidosis if severely dehydrated

In that case, injectable semaglutide may be more up your alley, as its taken weekly

Regular check-ins with your healthcare provider can help assess your progress and make necessary adjustments to your treatment plan

But as interest in semaglutide for weight loss continues to grow, health care professionals are finding ways to manage the demand

Your healthcare provider can discuss strategies to improve tolerability, adjust your treatment plan, or recommend another option if appropriate